Additional information
| Strength | STARTING DOSE 2.5MG, STEP UP DOSE 5MG, STEP UP DOSE 7.5MG, STEP UP DOSE 10MG, STEP UP DOSE 12.5MG, HIGHEST DOSE 15MG |
|---|---|
| Quantity | 1 PEN (4 DOSES), 2 PENS (8 DOSES), 3 PENS (12 DOSES) |
Mounjaro is a once-weekly prescription injection containing tirzepatide, used to support weight management in eligible adults. It works by influencing appetite and blood sugar regulation, helping to reduce hunger, manage cravings and support better portion control alongside healthy lifestyle changes.
£149.99 – £899.97Price range: £149.99 through £899.97

Safe & compliant prescribing

UK-Registered Pharmacy

Quick, hassle-free online consultation

Your data is 100% protected

Next-day UK delivery available

NHS Providing Service since 2020
| Strength | STARTING DOSE 2.5MG, STEP UP DOSE 5MG, STEP UP DOSE 7.5MG, STEP UP DOSE 10MG, STEP UP DOSE 12.5MG, HIGHEST DOSE 15MG |
|---|---|
| Quantity | 1 PEN (4 DOSES), 2 PENS (8 DOSES), 3 PENS (12 DOSES) |
Treatment Information, Doses and Pricing
Mounjaro is a prescription-only medicine containing tirzepatide. It is administered once a week and is licensed in the UK for weight management in eligible adults when used alongside a reduced-calorie diet and increased physical activity.
For further information about how tirzepatide is assessed and recommended for weight management within the NHS, you can read the NICE guidance on tirzepatide for managing overweight and obesity (TA1026). NICE guidance includes specific recommendations and eligibility criteria for NHS-funded treatment.
Before Mounjaro can be prescribed, an appropriate clinical assessment is required. The prescriber will consider your BMI, medical history, existing health conditions, current medicines and other relevant information before deciding whether treatment is suitable.
At Chesterfield Delivery Pharmacy, prescription weight-management treatment is only supplied following an appropriate consultation and clinical approval.
Please check our delivery information before ordering for the latest dispatch and delivery arrangements.
Mounjaro UK Price Information
The cost of Mounjaro varies according to the strength prescribed and the number of pens required.
Treatment normally starts at the lowest dose before being gradually increased, so your prescribed strength may change during treatment.
| Mounjaro Dose | 1 Pen (4 Doses) | 2 Pens (8 Doses) | 3 Pens (12 Doses) |
|---|---|---|---|
| 2.5 mg | £149.99 | £299.98 | £449.97 |
| 5 mg | £184.99 | £369.98 | £554.97 |
| 7.5 mg | £234.99 | £469.98 | £704.97 |
| 10 mg | £259.99 | £519.98 | £779.97 |
| 12.5 mg | £279.99 | £559.98 | £839.97 |
| 15 mg | £299.99 | £599.98 | £899.97 |
Prices should be checked against the current Chesterfield Delivery Pharmacy price list before publication or ordering.
The dose prescribed should always be based on clinical suitability rather than price.
What is Mounjaro?
Mounjaro is a once-weekly injectable medicine containing the active ingredient tirzepatide.
For weight management, it is licensed for eligible adults with obesity or overweight who meet the appropriate clinical criteria. Tirzepatide is also licensed for the treatment of type 2 diabetes in appropriate patients.
Mounjaro works by acting on two naturally occurring hormone pathways called GIP and GLP-1. These hormones are involved in appetite regulation, digestion and blood glucose control.
For people receiving Mounjaro for weight management, treatment may help reduce hunger, increase feelings of fullness and make it easier to manage portion sizes.
Mounjaro should be used alongside appropriate dietary changes and regular physical activity rather than as a replacement for a healthy lifestyle.
What is Mounjaro used for?
For adult weight management, Mounjaro may be considered for people with:
Relevant conditions can include:
Mounjaro is also licensed to help manage blood glucose in people with type 2 diabetes who meet the relevant clinical criteria.
Eligibility is not determined by BMI alone. Your prescriber will review your overall health and medical history before deciding whether tirzepatide is appropriate.
How does Mounjaro work?
Tirzepatide acts on both GIP and GLP-1 receptors.
These hormones play several roles within the body, including helping regulate appetite and blood glucose.
Mounjaro can:
The dual GIP and GLP-1 mechanism distinguishes tirzepatide from medicines that act only on the GLP-1 receptor.
Individual responses vary, and Mounjaro should always be used exactly as prescribed.
What is the Mounjaro dosing schedule?
Mounjaro treatment starts at a low dose and is increased gradually.
The usual starting dose is:
The dose is then normally increased to:
If additional treatment benefit is required and the medicine is being tolerated, the dose can be increased in 2.5 mg steps after at least four weeks on the current dose.
Available strengths include:
The recommended adult maintenance doses are generally 5 mg, 10 mg or 15 mg once weekly, depending on individual response and clinical requirements.
The maximum dose is 15 mg once weekly.
Never increase your dose yourself. Your prescriber will advise when and whether your dose should change.
How much weight could I lose with Mounjaro?
The amount of weight lost while taking Mounjaro differs considerably between individuals.
In the SURMOUNT-1 clinical study involving adults with obesity or overweight without type 2 diabetes, participants receiving tirzepatide alongside dietary and physical activity support experienced significant average weight reduction over 72 weeks.
In one trial analysis, average body-weight reductions were approximately:
These figures are averages from a clinical trial and should not be interpreted as a guarantee of individual results.
Your response may depend on:
A weight-loss calculator can provide an illustration based on percentage weight reduction, but it cannot predict exactly how much weight you will lose.
Clinical Review and Pharmacy OversightThe treatment information provided on this website is reviewed under the clinical governance of Rayaz Ahmed, Superintendent Pharmacist at Chesterfield Delivery Pharmacy (GPhC: 2082789).
As a UK-registered pharmacist, Rayaz Ahmed oversees the professional and clinical standards followed by Chesterfield Delivery Pharmacy, including patient safety, medicines governance and the quality of healthcare information presented across our online pharmacy.
All prescription medicines supplied through Chesterfield Delivery Pharmacy are subject to an appropriate clinical assessment before treatment is approved. A qualified prescriber will review relevant information such as your medical history, current medicines, existing health conditions, allergies and overall suitability for the requested treatment before deciding whether a prescription can be issued.
This applies across our range of prescription treatments, including medicines for weight management, men’s health, women’s health, skin conditions, allergies, infections and other eligible health concerns.
Our treatment information is reviewed and updated where appropriate to help ensure it remains consistent with current UK prescribing information, regulatory standards and recognised clinical guidance.
Superintendent Pharmacist
Rayaz Ahmed
Superintendent Pharmacist
GPhC Registration Number: 2082789
Possible Side Effects of Mounjaro
Like all medicines, Mounjaro can cause side effects, although not everybody will experience them.
Digestive symptoms are among the most frequently reported side effects, particularly when treatment begins or when the dose is increased.
Common side effects can include:
Some digestive side effects may improve as your body becomes accustomed to treatment.
More serious Mounjaro side effects
Some reactions require prompt medical attention.
Pancreatitis
Acute pancreatitis has been reported in people taking tirzepatide.
Seek immediate medical attention if you develop severe and persistent abdominal pain, particularly if the pain spreads towards your back. It may occur with or without vomiting.
Low blood sugar
The risk of hypoglycaemia may increase if Mounjaro is used alongside insulin or certain diabetes medicines known as sulphonylureas.
Possible symptoms include:
Your diabetes medicines may need to be adjusted by your healthcare professional.
Serious allergic reactions
Rare but serious allergic reactions can occur.
Seek urgent medical assistance if you develop:
Dehydration and kidney problems
Vomiting and diarrhoea can result in dehydration.
Significant fluid loss may worsen kidney function, particularly in people who already have kidney problems.
Make sure you drink enough fluids and seek medical advice if vomiting or diarrhoea becomes severe or persistent.
Gallbladder problems
Gallstones and inflammation of the gallbladder can occur in some patients.
Seek medical advice if you develop severe upper abdominal pain, particularly if accompanied by fever, vomiting or yellowing of the skin or eyes.
When should I speak to my healthcare professional?
Contact your prescriber if side effects:
Always read the Patient Information Leaflet supplied with your medicine for the complete list of possible side effects.
How should Mounjaro be stored?
Mounjaro KwikPens should be stored correctly to maintain the quality of the medicine.
Before use:
After first use, a Mounjaro KwikPen may be kept outside the refrigerator for up to 30 days, provided the temperature does not exceed 30°C.
The pen should be discarded after this period, even if medicine remains inside.
Always check the expiry date and follow the storage instructions provided in the Patient Information Leaflet.
Mounjaro Warnings and Precautions
Mounjaro is a prescription-only medicine and is not suitable for everyone.
Before treatment begins, tell your prescriber about your complete medical history and all medicines you currently use.
Extra care may be required if you:
Mounjaro is not licensed for weight management in people under 18 years of age.
Mounjaro is not used as a treatment for type 1 diabetes.
Do not use Mounjaro if you are allergic to tirzepatide or any of the ingredients contained in the medicine.
Mounjaro and pregnancy
Mounjaro should not be used during pregnancy.
If you are planning to become pregnant, tirzepatide should normally be stopped at least one month before a planned pregnancy.
Speak to your healthcare professional immediately if you become pregnant while receiving treatment.
Mounjaro and contraception
Tirzepatide delays stomach emptying and may affect the absorption of some oral medicines.
For women with overweight or obesity who use an oral contraceptive pill, reduced contraceptive effectiveness cannot be completely excluded when Mounjaro treatment begins or the dose is increased.
Current UK prescribing guidance advises considering:
This additional precaution should generally be used for four weeks after starting Mounjaro and for four weeks following each dose increase.
Discuss contraception with your prescriber if this applies to you.
Mounjaro and breastfeeding
If you are breastfeeding or planning to breastfeed, discuss this with your prescribing healthcare professional.
Current UK prescribing information indicates that tirzepatide may be considered during breastfeeding in some circumstances, but the decision should be made individually following professional medical advice.
Mounjaro and surgery or sedation
Mounjaro can slow stomach emptying.
If you are due to have surgery or another procedure requiring general anaesthesia or deep sedation, make sure the medical team knows that you are taking tirzepatide.
Your healthcare professionals will advise you what to do before the procedure.
How to use a Mounjaro KwikPen
Mounjaro is available as a multi-dose KwikPen containing four weekly doses of the same strength.
Always follow the instructions supplied with your particular pen and the directions given by your prescriber.
Mounjaro is injected under the skin into one of the recommended areas:
If injecting into the back of the upper arm, another person should normally administer the injection.
Rotate your injection site each week rather than repeatedly injecting into exactly the same area.
Mounjaro should not be injected into a vein or muscle.
Before injecting Mounjaro
Before each injection:
Needles are not supplied as part of the Mounjaro KwikPen pack.
Never share your Mounjaro pen with another person.
Dispose of used needles immediately in a suitable sharps container.

What ingredients are in Mounjaro?
The active ingredient in Mounjaro is tirzepatide.
Tirzepatide is a dual GIP and GLP-1 receptor agonist used for appropriate patients requiring treatment for weight management or type 2 diabetes.
The Mounjaro KwikPen also contains:
The Mounjaro KwikPen therefore does contain ingredients used as preservatives, including phenol and benzyl alcohol.
If you have any known allergies or sensitivities, discuss them with your prescriber before starting treatment.
Important Information
Mounjaro contains tirzepatide and is a prescription-only medicine.
Treatment must only be used after an appropriate clinical assessment and exactly as directed by your prescriber.
Completing a consultation with Chesterfield Delivery Pharmacy does not guarantee that Mounjaro will be prescribed. Treatment will only be supplied where a qualified healthcare professional considers it appropriate.
Always read the Patient Information Leaflet supplied with your medication before using Mounjaro.
The information provided on this page is intended for general educational purposes and does not replace personalised advice from your doctor, pharmacist or prescribing healthcare professional.








This website sells age-restricted products. Please confirm you are 18 years of age or older to continue.
Sorry, you must be 18 years or older to access this website.
Leave Site
Reviews
There are no reviews yet.